Four signaling pathways—TGFβ (related to SRC), IL-1 (related to FOS), CXCL, and VEGF (related to CXCL2), were highlighted due to their significant roles in tumor occurrence, progression, and deterioration. This evidence concerns the gene SRC and neoplasm.